Alpha 1-antitrypsin deficiency secondary prevention: Difference between revisions
Mazia Fatima (talk | contribs) |
Mazia Fatima (talk | contribs) |
||
| Line 9: | Line 9: | ||
==Secondary Prevention== | ==Secondary Prevention== | ||
Secondary prevention strategies following alpha1-antitrypsin deficiency (AATD) includes : | Secondary prevention strategies following alpha1-antitrypsin deficiency (AATD) includes :<ref name="pmid20301692">{{cite journal |vauthors=Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Mefford HC, Stephens K, Amemiya A, Ledbetter N, Stoller JK, Lacbawan FL, Aboussouan LS |title= |journal= |volume= |issue= |pages= |year= |pmid=20301692 |doi= |url=}}</ref><ref name="pmid18565211">{{cite journal |vauthors=Fregonese L, Stolk J |title=Hereditary alpha-1-antitrypsin deficiency and its clinical consequences |journal=Orphanet J Rare Dis |volume=3 |issue= |pages=16 |year=2008 |pmid=18565211 |pmc=2441617 |doi=10.1186/1750-1172-3-16 |url=}}</ref> | ||
The most effective secondary prevention strategy for alpha1-antitrypsin deficiency (AATD) patient is to avoid cigarette smoking. | The most effective secondary prevention strategy for alpha1-antitrypsin deficiency (AATD) patient is to avoid cigarette smoking. | ||
Revision as of 01:13, 16 December 2017
|
Alpha 1-antitrypsin deficiency Microchapters |
|
Differentiating Alpha 1-antitrypsin deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Alpha 1-antitrypsin deficiency secondary prevention On the Web |
|
American Roentgen Ray Society Images of Alpha 1-antitrypsin deficiency secondary prevention |
|
Alpha 1-antitrypsin deficiency secondary prevention in the news |
|
Blogs on Alpha 1-antitrypsin deficiency secondary prevention |
|
Directions to Hospitals Treating Alpha 1-antitrypsin deficiency |
|
Risk calculators and risk factors for Alpha 1-antitrypsin deficiency secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Secondary prevention strategies following alpha1-antitrypsin deficiency (AATD) includes effective secondary prevention strategy for alpha1-antitrypsin deficiency (AATD) patient is to avoid cigarette smoking. Smoking accelerates the progression of emphysema in severely deficient individuals by as much as 15 years when compared to their nonsmoking controls. Pneumonia and annual influenza vaccines will help prevent respiratory infections in patients with alpha1-antitrypsin deficiency (AATD).The ATS/ERS AAT Deficiency Task Force recommends that all exacerbations with purulent sputum be treated with early antibiotic therapy. Prompt and effective treatment of infections may provide protection from additional lung injury from an influx of neutrophils into the alveolus.
Secondary Prevention
Secondary prevention strategies following alpha1-antitrypsin deficiency (AATD) includes :[1][2]
The most effective secondary prevention strategy for alpha1-antitrypsin deficiency (AATD) patient is to avoid cigarette smoking.
Smoking accelerates the progression of emphysema in severely deficient individuals by as much as 15 years when compared to their nonsmoking controls.
Pneumonia and annual influenza vaccines will help prevent respiratory infections in patients with alpha1-antitrypsin deficiency (AATD).
The ATS/ERS AAT Deficiency Task Force recommends that all exacerbations with purulent sputum be treated with early antibiotic therapy. Prompt and effective treatment of infections may provide protection from additional lung injury from an influx of neutrophils into the alveolus.
References
- ↑ Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean L, Mefford HC, Stephens K, Amemiya A, Ledbetter N, Stoller JK, Lacbawan FL, Aboussouan LS. PMID 20301692. Vancouver style error: initials (help); Missing or empty
|title=(help) - ↑ Fregonese L, Stolk J (2008). "Hereditary alpha-1-antitrypsin deficiency and its clinical consequences". Orphanet J Rare Dis. 3: 16. doi:10.1186/1750-1172-3-16. PMC 2441617. PMID 18565211.